Cargando…

Effect of glucocorticosteroids on epidermal Langerhans cells

The effects of topical and systemic administration of various glucocorticoids on the density of epidermal Langerhans cells (LC) were studied in guinea pigs. Glucocorticoids, such as betamethasone dipropionate and valerate, caused a marked decrease in LC demonstrable by staining for cell membrane ATP...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186563/
https://www.ncbi.nlm.nih.gov/pubmed/6459400
_version_ 1782145970835816448
collection PubMed
description The effects of topical and systemic administration of various glucocorticoids on the density of epidermal Langerhans cells (LC) were studied in guinea pigs. Glucocorticoids, such as betamethasone dipropionate and valerate, caused a marked decrease in LC demonstrable by staining for cell membrane ATPase activity and Ia antigens. By electronmicroscopy, LC also showed morphologic alterations. The observed decrements in LC density correlated with the concentration and known vasoconstrictive potency of the glucocorticoids administered. The anti-inflammatory action of glucocorticoids in skin disorders may, at least in part, be through their ability to alter epidermal LC, thus interfering with the antigen-presenting functions of these cells.
format Text
id pubmed-2186563
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21865632008-04-17 Effect of glucocorticosteroids on epidermal Langerhans cells J Exp Med Articles The effects of topical and systemic administration of various glucocorticoids on the density of epidermal Langerhans cells (LC) were studied in guinea pigs. Glucocorticoids, such as betamethasone dipropionate and valerate, caused a marked decrease in LC demonstrable by staining for cell membrane ATPase activity and Ia antigens. By electronmicroscopy, LC also showed morphologic alterations. The observed decrements in LC density correlated with the concentration and known vasoconstrictive potency of the glucocorticoids administered. The anti-inflammatory action of glucocorticoids in skin disorders may, at least in part, be through their ability to alter epidermal LC, thus interfering with the antigen-presenting functions of these cells. The Rockefeller University Press 1982-01-01 /pmc/articles/PMC2186563/ /pubmed/6459400 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Effect of glucocorticosteroids on epidermal Langerhans cells
title Effect of glucocorticosteroids on epidermal Langerhans cells
title_full Effect of glucocorticosteroids on epidermal Langerhans cells
title_fullStr Effect of glucocorticosteroids on epidermal Langerhans cells
title_full_unstemmed Effect of glucocorticosteroids on epidermal Langerhans cells
title_short Effect of glucocorticosteroids on epidermal Langerhans cells
title_sort effect of glucocorticosteroids on epidermal langerhans cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186563/
https://www.ncbi.nlm.nih.gov/pubmed/6459400